Stocks / Pharmaceuticals
KURAPharmaceuticals
Kura Oncology, Inc.
$11.761d +4.5%5d +0.2%settled close · 2026-09-17
Mkt cap $713M (3/25)β 0.7652w $8.57–13.84Shares 88.3MInd. Pharmaceutical PreparationsNasdaq since 2015Emp. 260HQ San Diego, CAkuraoncology.com
Who’s talkingIdea Scout · free
Who’s talking about KURA
No tracked investor commentary on KURA yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 2 Nov 2026
Confirmed date · consensus EPS -0.84. Reactions below are the next settled session over the prior close.
| Report | When | EPS actual vs est. | Reaction |
|---|---|---|---|
| 12 Aug 2026 | after the close | -0.77 vs -0.90 | +3.0% |
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where KURA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 14 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-11 | ||||||
| 2026-08-25 | ||||||
| 2026-08-19 | ||||||
| 2026-08-18 | ||||||
| 2026-08-14 | ||||||
| 2026-08-13 | ||||||
| 2026-07-09 | ||||||
| 2026-07-08 | ||||||
| 2026-07-07 | ||||||
| 2026-07-06 | ||||||
| 2026-06-24 | ||||||
| 2026-06-22 | ||||||
| 2026-05-21 | ||||||
| 2026-05-20 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
KURA is in this morning’s Brief.
Get The Brief — $20/mo →